###### Strengths and limitations of this study

-   Data envelopment analysis was used to determine the extent of inefficiency in health systems across Asia.

-   We extracted health systems level indicators from the widely used World Bank World Development Indicators database and the WHO Open Data Repository.

-   Due to data unavailability, we used health system outcomes in addressing the health systems efficiency rather than true health system output.

Background {#s1}
==========

In Asia, there are approximately 4.4 billion people spread across highly diverse countries, from economic powerhouses like China and Singapore to poorer economies such as Laos, Cambodia and Myanmar.[@R1] Overall, the continent is often cited as the fastest growing and most dynamic region in the world. Over the past number of years, Asian societies have also made impressive progress in ensuring better healthcare services, especially those targeted towards improving maternal and infant health and increasing life expectancy.[@R2] However, whether economic gains have translated to efficient health systems across the region is still not well studied.

It is important that the healthcare resources in Asia are used efficiently. In Asia, generally government spending on healthcare is low compared with total health expenditure, and it is often not focused on those who need it most.[@R3] For example, in the South Asia region, governments spend 31% of total health expenditure, which is about 1% of gross domestic product (GDP).[@R4] In many Asian countries, personal health expenses or out-of-pocket payments are a major cause of poverty.[@R1] For instance, from a study of 11 Asian countries, it was found that 78 million people are pushed into poverty due to out-of-pocket spending for healthcare.[@R7] Ageing populations and non-communicable diseases that are often preventable but expensive to treat (eg, diabetes and cancers linked to tobacco) impose and will continue to impose heavy costs on households and public health budgets. Moreover, a major challenge for Asian countries is the control and prevention of different communicable diseases (eg, HIV/AIDS, tuberculosis and polio) due to the movement of people across borders and the exchange of goods.[@R8]

In light of this, it is very important that the health systems of these countries are efficient in using their resources. The WHO has estimated that due to inefficiency about 20%--40% of total healthcare resources are being wasted per year among its member countries. Furthermore, this rate is higher in low-income and middle-income countries.[@R9] In Asia, the variation in efficiency across income groups and contexts can perhaps lead to lessons learnt in addressing it. In order to address inefficiency, Asia's health systems can look towards different dimensions of performance such as their effectiveness, efficiency, access, equity and quality.[@R10] A great deal of practitioner and academic literature have analysed the relationship between the efficient production of health services and universal health coverage as well as the widespread importance of measuring overall health system performance.[@R9]

Assessing the efficiency of healthcare systems is a difficult process as analyses often encounter methodological problems, particularly due to the need for appropriate and valid outcome indicators.[@R12] Despite the empirical difficulties in applying efficiency concepts to health systems, efficiency can be measured on both micro and macro levels.[@R13] Measuring health system efficiency at a macro level is particularly important in order to understand health system performance across the globe and take required action to minimise inefficiency.[@R11]

A number of studies have analysed the healthcare efficiency in the Americas,[@R15] Western Europe[@R17] and Asia[@R19] to shed light on the efficiency of different national healthcare systems. A systematic review on measuring efficiency related to several aspects of healthcare performed by Hollingsworth *et al*.[@R21] Dimas *et al* [@R22] evaluated the productivity of Greek public hospitals and found that productivity changes were dominated by technical change. Additionally, Zere *et al* [@R23] measured the technical efficiency and productivity of hospitals in South Africa and examined the impact of hospital characteristics on efficiency and productivity.[@R23]

Several studies have reported on different determinants of health system efficiency. For example, a study conducted in China reported that GDP per capita, proportion of primary health worker and population density were the key determinants of the efficiency in Chinese health system.[@R24] Another study in the Canadian context reported that readmission, obesity and smoking and average income of the population are key determinants of health system efficiency.[@R25]

In an international study of efficiency in 170 Asian and non-Asian countries, it was observed that Asian countries were comparatively in the middle with respect to health system efficiency scores.[@R26] This indicates that there is room for improvement to optimise health benefits from the available health sector resources. In this region, a number of studies have been conducted at the country level to address health systems efficiency,[@R27] but cross-country comparison of the health system efficiency is limited.[@R29]

Asian countries are not homogeneous in terms of area, population and economic conditions; however, they have public health functions and a number of their health system outcomes are in common.[@R30] Many of the countries share similar health systems problems, including a high burden of diseases due to the geographical contiguity, disease patterns and social conditions and inadequate resources for healthcare. Understanding health systems efficiency in different Asian countries could promote shared learning and highlight key areas of best practice, as well as areas where improvement is needed. Furthermore, given geographical proximity and many strong relationships experienced with nearby countries, there is likely to be relative ease in the ability to practically understand, learn and apply nuance about healthcare systems from one country to another.

A study on the efficiency of health systems in this region will help to provide lessons through comparison across countries. This paper aims to achieve this goal through measuring the technical efficiency and scale efficiency of the healthcare systems of selected Asian countries.

Methods {#s2}
=======

This study employed two stages of efficiency analysis using cross-sectional data. In the first stage, data envelopment analysis (DEA) was used to estimate the country efficiency scores. In the second stage, a regression analysis and a bootstrap method were employed to identify the factors associated with the health system efficiency. The software package STATA V.13 was used for all of the analyses.

Data sources {#s2a}
------------

We used two main data sources: the WHO Data Repository[@R31] and World Development Indicators-2015 (WDI). According to the list of United Nations Statistics Division, there are 50 Asian countries and territories. Among these, 46 were used for this study.[@R32] Four countries and territories (Hong Kong, North Korea, Macao, and West bank and Gaza) were excluded due to missing data of selected variables in the WDI database.[@R5] However, selected variables for the study countries were not reported in WDI for every year. This problem is unavoidable in studies based on WDI data.[@R33] Earlier studies adopted two approaches to deal with such problem. First, they used a value from a slightly earlier year as in Anderson *et al* [@R33] and second, they used a smaller number of countries in the model as in Färe *et al* [@R34] and Grubaugh and Santerre.[@R35] Given the importance of including as many countries as possible to study technical efficiency using DEA, we opted for the first approach. However, to avoid missing variable, we used slightly earlier WDI statistics.

### Input and output variables {#s2a1}

A main assumption of the DEA model used in our analysis was that in Asian countries, the selected health outcomes are dependent on the inputs of healthcare resources. We selected the input variables as proxies for the quantity of inputs that a country devotes to healthcare (ie, health expenditure per capita) and outcome variables as the healthy life expectancy at birth (HALE) and infant mortality (per 1000 live births). The health expenditure per capita was extracted from the Global Health Expenditure database managed by the WHO. In this database, there are national health expenditure statistics for more than 190 WHO Member States in line with the new System of Health Accounts 2011 (SHA 2011) framework. The SHA 2011 framework was developed by Organisation for Economic Co-operation and Development (OECD) to rigorously track health expenditure (eg, by all financial sources, by all services) at the national level and to enable comparability across countries. The capital expenditure (eg, infrastructure) was included in the total health expenditure estimation.[@R31] The relationship between health expenditure and outcomes considered here is consistent with the view that health expenditure has diminishing returns, or additional expenditure beyond a certain level has relatively smaller incremental effect on life expectancy or infant mortality.[@R36] To be clear, reduction in infant mortality and increase in life expectancy signify improvement in the health outcomes of a country. Some studies have included life expectancy at birth as an outcome variable[@R37]; however, it is argued that quality of life matters as much as, if not more than, quantity of life, and therefore, life expectancy should be a weighted health quality measure. As a result, HALE has been incorporated as a proxy of health quality as the outcome of health systems. Also, it is important to note that instead of using the infant mortality directly in the DEA model, we used the inverse of infant mortality as the model assumes that inputs and outputs are isotonic (ie, increased input reduces efficiency as well as increased output increases efficiency).[@R40] Without this correction, a higher infant mortality figure would have been said to incorrectly contribute to a better health system outcome.

#### Data envelopment analysis {#s2a1a}

DEA is a widely used non-parametric method that identifies an efficiency frontier by using linear programming techniques and the distance of each decision-making unit (DMU) to the frontier. Of the two types of efficiency analysis approach namely DEA and Stochastic Frontier Analysis, we choose DEA. The key advantage of the DEA approach in this analysis is that it can incorporate multiple inputs and outputs, which are measured in different units.

One type of DEA model, developed by Charnes, Cooper and Rhodes (CCR), assumes that production has constant returns to scale (CRS), meaning any change in the input will result in a proportionate change in the output.[@R41] Another model proposed by Banker, Charnes and Cooper (BCC) assumes that production has variable returns to scale (VRS) implying an increase in the input will result in either an increase or a decrease in the output. The latter methodology is particularly useful for this study since it aims to measure the efficiency related to organisational units (ie, the health systems of different countries), which use numerous resources to produce multiple outputs and accommodate a more flexible assumption of VRS.[@R26] This is more realistic and reflective of changes in the real world.[@R27]

We measured scale efficiency to see whether the health systems of Asian countries are operating at their optimal sizes or not.[@R43] The size of health systems is a major political decision in Asian countries. To some extent, it depends on how the policy makers or government are prioritising health among other competing public services (eg, education, military and electricity).[@R44] Scale efficiency scores provide information on the optimality of a DMU size; in this case, the health system of a country. When a production unit (DMU) operates at CRS, technical efficiency is equal to scale efficiency. However, when DMUs are not operating at optimum scale, technical efficiency measured with the CCR model may be altered by scale efficiency. The BCC model, which defines production through VRS, can incorporate the impact of scale efficiency in the measurement of technical efficiency. The scale efficiency is measured as the ratio of CRS technical efficiency scores and VRS technical efficiency scores.[@R45]

When it comes to DEA studies comparing countries, both the input-oriented and output-oriented models have been adopted for analysis. An output-oriented DEA model aims to maximise the outputs with a given amount of inputs, while input-oriented models focus on minimising the inputs used to obtain a certain amount of output. Many studies have been carried out using DEA to assess the efficiency of healthcare systems using the two approaches in both high-income and low-income countries.[@R28] In this study, an output-oriented DEA model was deemed more appropriate based on the premise that the input (ie, per capita expenditure) is likely to be less flexible. In other words, health system stewards are likely to have more leverage in controlling outputs through innovative programming and improvements in provided healthcare, rather than by increasing spending and resources.

#### Output-oriented model {#s2a1b}

The output-oriented technical efficiency model focuses on increasing output without changing the quantity of inputs used. The objective of the model for solving each particular DMU (health system) is to maximise the efficiency score (denoted $\phi$) meaning the amount by which all outputs can be improved for each country's health system under consideration while holding input constant.

The output-oriented DEA model is specified as follows:

$$Max{}\ \phi = \sum O_{r}Y_{rj_{0}} + O_{0}$$

Subject to constraints:

$$\sum\limits_{i = 1}^{m}V_{i} + X_{ij_{0}} = 1$$

$$\sum\limits_{r = 1}^{s}O_{r} + Y_{rj} - \sum V_{r}X_{ij} + O_{0} \leq 0,\ j = 1,\ldots,n$$

$$O_{r},\ V_{i}\  \geq 0$$

$$O_{0} > 0,\ or\ O_{0} = 0\ or\ O_{0} < 0;$$

where,

Y~rj~=amount of output r from country j.

X~ij~=amount of input i to country j.

O~r~=weight given to output r.

V~i~=weight given to input i.

n=number of countries.

s=number of outputs.

m=number of inputs.

O~0~ \>0 defines increasing returns to scale, O~0~=0 defines CRS, and O~0~ \<0 defines decreasing returns to scale.

The technical efficiency scores is defined by $\phi$ and, it ranges between 0.00 and 1.00; if it is equal to 1.00, then the production from the DMU is efficient; while if it is less than 1.00, the DMU is inefficient.

#### Explaining efficiency through regression analysis {#s2a1c}

One of the limitations of the DEA approach is the serial correlation of the efficiency scores generated through this approach. In other words, the correlation between inputs and outputs, and consequently with the estimated efficiency scores resulted in this serial correlation. Thus, the scores of one DMU is not independent on that of the other DMUs. To handle this limitation, scholars such as Ramalho *et al* [@R49] and McDonald[@R50] have argued that econometric models like probit, logit and truncated regression (Tobit) can be used for second-stage analysis for identifying impact of environmental variables on efficiency. However, scholars such as Simar and Wilson[@R51] have argued that the conventional statistical inferences are inappropriate in the second-stage regression due to the bias of the DEA score and recommend using bootstrap methods.[@R51] Afonso and St. Aubyn[@R52] showed in their empirical study that the censored normal Tobit regression and bootstrap algorithms yield very similar results. However, we have adopted both the Tobit model and smoothed bootstrap model in explaining the association with health system efficiency to be comprehensive.

The VRS efficiency scores computed using the DEA model were regressed against a few health service productions (eg, physician and beds density per 1000 population) and some environmental factors ([table 1](#T1){ref-type="table"}). Since, by definition, the DEA scores range between 0 and 1, and some of the data tend to concentrate on these boundary values (ie, censored for the DMUs with a value at one), ordinary least squares cannot estimate the regression. Therefore, a Tobit model is suitable for such regression. For the convenience of calculation, we assumed a censoring point at zero in this model. As a result, the efficient DMUs will have a score of zero, and the inefficient DMUs will have score greater than zero. Following Zere,[@R53] we applied this method by transforming VRS technical efficiency scores into VRS inefficiency scores and leaving censoring at 0 as follows.

###### 

Descriptive statistics of input, outcome, and explanatory variables

  Characteristics/description                                 Mean      Median   SD        Minimum   Maximum   Source
  ----------------------------------------------------------- --------- -------- --------- --------- --------- --------
  Input variable                                                                                               
   Health expenditure per capita, PPP                         1133.71   663.94   1157.72   88.03     4405.13   WDI
  Outcome variables                                                                                            
   Healthy life expectancy at birth (years)                   64.29     65.2     5.1       53.2      75.9      WHO
   Infant mortality (per 1000 live births)                    19.9      13.9     15.8      2.0       65.7      WDI
  Explanatory variables for Tobit model                                                                        
   Physicians (per 1000 people)                               1.6       1.6      1.1       0.1       4.8       WDI
   Hospital beds (per 1000 people)                            2.9       2.1      2.7       0.1       13.7      WDI
   Smoking prevalence, males (% of adults)                    42.2      42.2     10.5      18.9      71.8      WDI
   Primary completion rate, total (% of relevant age group)   96.5      97.9     11.4      66.7      116.5     WDI

PPP, purchasing power parity; SD, standard deviation; WDI, World Development Indicators-2015.

$$Inefficiency\ score\  = \ \left( \frac{1}{VRS\ technical\ efficiency\ score} \right) - 1$$

The Tobit regression model used variables representing access to healthcare and health status. Guided by several similar studies, physician density (the number of physicians per 1000 population) and bed density (the number of inpatient beds per 1000 population) were selected as determinants of access to healthcare.[@R35] In addition to healthcare, the health status of individuals is determined by the lifestyle and behaviours; therefore, we also included two environmental factors as determinants of efficiency, namely smoking prevalence among adult male (percentage of adults) and primary education completion rate of relevant age group. The relevant age group for the primary completion rate is defined as the number of new entrants (enrolments minus repeaters) in the last grade of primary education (regardless of age), divided by the population at the entrance age for the last grade of primary education of a country.[@R55] The adverse health effect of smoking consequently affects health outcomes and also the health system efficiency.[@R25] Education is found to be an important factor in determining individual health status. Higher educational attainment is associated with higher income which, in turn, secures a healthy living environment and access to healthcare.[@R57] Additionally, we included population density (population living per square kilometre of land area) as the control of efficiency. This is because population density can affect the quality of healthcare services.

The Tobit regression models were specified as follows:

$$Ineff_{i} = \begin{matrix}
{\beta_{0} + \beta_{1}\ Phy_{i} + \beta_{2}\ Beds_{i} + \beta_{3}\ Primary\_ edu_{i} +} \\
{\beta_{4}\ Smoking_{i} + \beta_{5}\ Inc_{i} + \beta_{5}\ Pop\_ density_{i} + \varepsilon_{i}} \\
\end{matrix}$$

where,

Ineff=the technical inefficiency score; continuous variable.

Phy=physician density; categorical variable (1=fewer than one physician; 2=1--2 physicians, 3=more than two physicians).

Beds=beds density; categorical variable (1=fewer than one bed, 2=more than one to less than or equal to three beds, 3=more than three to less than or equal to five beds, 4=more than five beds).

Inc=income group of the country; categorical variable (1=low- and lower middle-income, 2=upper middle-income, 3=high-income).

Pop_density=population density; categorical variable (1=fewer than or equal to 100, 2=more than 100 to less than or equal to 200, 3=more than 200).

Finally, ε ~i~ was the stochastic error term.

We submitted the initial DEA scores in a smoothed bootstrap method design by Simar and Wilson[@R51] to estimate the robust efficiency score from the bootstrapped regression analysis to identify factors associated with these scores. The simarwilson command in STATA V.13 was applied in the analysis using externally estimated DEA scores (algorithm \#1).[@R58]

#### Sensitivity analysis {#s2a1d}

The efficiency scores can be affected by the number of inputs and outputs used in DEA in relation with the number of DMUs. The scores can be overestimated if the number of DMUs is relatively small compared with the number of inputs or very large compared with the number of inputs and outputs.[@R59] It is suggested that the number of DMUs should be at least three times of the inputs and outputs variables.[@R61] In our model, the number of DMUs[@R46] is more than three times of the number of inputs and outputs,[@R9] and this is not a binding constraint for this study.

There is a possibility that choosing different variables in the DEA model may produce inconsistent results such as inconsistent efficiency estimate. There is no test to assess the suitability of a particular model specification in DEA.[@R63] Therefore, we carried out a sensitivity analysis of the efficiency scores by running the DEA model several times using different combinations of input and outcome variables. Different specifications of the DEA models were considered (eg, dropping the efficient countries, using HALE at age 60 years as input, using health expenditure per capita at current US\$ as input, and excluding countries with any missing variable for the year 2015) for testing the sensitivity of our main model.

#### Patient and public involvement {#s2a1e}

The study used secondary data from WHO and WDI databases. No patients were involved in this study. Study findings will be shared with the stakeholders, including local community groups in community meetings and at national or regional conferences.

Results {#s3}
=======

The descriptive statistics of the selected input, outcome and environmental variables are shown in [table 1](#T1){ref-type="table"}. The per capita health expenditure ranges from a minimum of US\$88.03 (Bangladesh) to a maximum of US\$4405.13 (Japan) with a mean, median, and SD of 1133.71, 663.94 and 1157.72 respectively. The number of physicians per 1000 people ranges from a minimum of 0.1 at Timor-Leste to maximum 4.8 at Georgia. However, the number of inpatient beds per 1000 people is the smallest in Iran (0.1) and the highest in Japan (13.7). The average smoking prevalence of the adult male people among the studied countries is 42.2% and average primary education completion rate is 96.5% of the relevant age group.

Among the countries analysed, HALE at birth was a minimum of 53.2 years in Afghanistan and a maximum of 75.9 years in Singapore. The infant mortality rate ranged from 2.0 deaths per 1000 live births in Japan to 65.7 deaths per 1000 live births in Pakistan. On average, there were 19.9 deaths per 1000 live births in the studied countries. The scatter matrix of the input and output variables shows that inputs, for instance, increase in per-capita healthcare expenditure was associated with improved health outcomes (eg, HALE at birth and reduced infant mortality) ([figure 1](#F1){ref-type="fig"}).

![Association across health systems input and outcome.](bmjopen-2018-022155f01){#F1}

The mean CRS and VRS technical efficiency scores were 0.780 and 0.919, respectively ([table 2](#T2){ref-type="table"}). Whereas, the mean scale efficiency score was 0.847. Considering VRS efficiency, Afghanistan has the lowest score of 0.812. Both VRS and CRS technical efficiency scores were positively correlated with per capita health expenditure, HALE at birth and negatively correlated with infant mortality (online [supplementary table 1](#SP1){ref-type="supplementary-material"}).
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###### 

Technical and scale efficiency scores of the health systems in Asian countries

  Country name           CRS technical efficiency   VRS technical efficiency   Scale efficiency   Returns to scale
  ---------------------- -------------------------- -------------------------- ------------------ ------------------
  Afghanistan            0.724                      0.812                      0.891              1
  Armenia                0.769                      0.946                      0.813              −1
  Azerbaijan             0.660                      0.902                      0.732              −1
  Bahrain                0.714                      0.910                      0.784              −1
  Bangladesh             1.000                      1.000                      1.000              0
  Bhutan                 0.775                      0.903                      0.858              1
  Brunei Darussalam      0.708                      0.920                      0.769              −1
  Cambodia               0.805                      0.916                      0.879              1
  China                  0.806                      0.975                      0.826              −1
  Cyprus                 1.000                      1.000                      1.000              0
  Georgia                0.751                      0.923                      0.813              −1
  India                  0.778                      0.892                      0.872              1
  Indonesia              0.746                      0.904                      0.826              1
  Iran                   0.678                      0.900                      0.754              −1
  Iraq                   0.683                      0.850                      0.803              1
  Israel                 0.874                      0.967                      0.904              −1
  Japan                  1.000                      1.000                      1.000              0
  Jordan                 0.743                      0.943                      0.789              −1
  Kazakhstan             0.695                      0.882                      0.788              1
  South Korea            0.886                      0.972                      0.911              −1
  Kuwait                 0.674                      0.885                      0.762              −1
  Kyrgyz Republic        0.806                      0.941                      0.856              1
  Laos                   0.818                      0.889                      0.920              1
  Lebanon                0.746                      0.910                      0.820              1
  Malaysia               0.778                      0.927                      0.839              1
  Maldives               0.730                      0.944                      0.773              −1
  Mongolia               0.737                      0.896                      0.823              1
  Myanmar                0.743                      0.872                      0.852              1
  Nepal                  0.861                      0.932                      0.924              1
  Oman                   0.692                      0.896                      0.772              −1
  Pakistan               0.827                      0.889                      0.930              1
  Philippines            0.779                      0.916                      0.850              1
  Qatar                  0.677                      0.903                      0.749              −1
  Saudi Arabia           0.624                      0.871                      0.716              −1
  Singapore              1.000                      1.000                      1.000              0
  Sri Lanka              0.904                      0.985                      0.917              −1
  Syria                  0.818                      0.848                      0.964              1
  Tajikistan             0.856                      0.964                      0.888              −1
  Thailand               0.791                      0.956                      0.828              −1
  Timor-Leste            0.823                      0.903                      0.912              1
  Turkey                 0.710                      0.916                      0.776              −1
  Turkmenistan           0.639                      0.859                      0.743              1
  United Arab Emirates   0.691                      0.889                      0.777              1
  Uzbekistan             0.784                      0.947                      0.828              −1
  Vietnam                0.845                      0.996                      0.849              −1
  Yemen                  0.727                      0.826                      0.881              1

  Mean (95% CI)   0.780 (0.752 to 0.808)   0.919 (0.905 to 0.933)   0.847 (0.824 to 0.87)   --
  --------------- ------------------------ ------------------------ ----------------------- ----
  Median          0.772                    0.913                    0.834                   --
  Minimum         0.624                    0.812                    0.716                   --
  Maximum         1                        1                        1                       --

CRS, constant returns to scale; VRS, variable returns to scale.

Out of 46 countries studied, only four (8.7%) countries showed the maximum level of efficiency (efficiency score 1.00) in VRS and CRS technical efficiency scale. All of these four countries showed scale efficiency of 1.00 implying that these countries created the best practice frontier based on their input and output combinations. Around 39.1% (18 countries) of the studied countries showed increasing returns to scale, 52.2% countries (24 countries) showed decreasing returns to scale and four efficient countries showed CRS production function of their health systems.

More than half of the countries (30 countries) had VRS efficiency, and five countries had CRS efficiency greater than 90% (online [supplementary figure 1](#SP1){ref-type="supplementary-material"}).

Result from Tobit regression and bootstrap analysis for associated factors with the inefficiency {#s3a}
------------------------------------------------------------------------------------------------

Tobit regression and smoothed bootstrap were used to relate VRS efficiency scores to two health service production variables and four environmental variables in two separate models ([table 3](#T3){ref-type="table"}). Negative associations with the inefficiency scores in the Tobit model represent positive relation of health system efficiency with the explanatory variables. However, positive associations with the explanatory variables in the smoothed bootstrap model represent positive relations of the health system efficiency with the explanatory variables.

###### 

Result from Tobit regression and smoothed bootstrap analysis

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                                                                      Tobit regression                Bootstrap analysis                                 
  ----------------------------------------------------------------------------- ------------------------------- -------------------- ----------------------------- --------
  Physician density (per 1000 population)                                                                                                                          

   1--2 physicians(ref=fewer than one physician)                                −0.0041 (−0.0437 to 0.0355)     0.8360               0.0069 (−0.02 to 0.0346)      0.6220

   More than two physicians(ref=fewer than one physician)                       0.0001 (−0.0495 to 0.0495)      0.9990               −0.0086 (−0.0424 to 0.026)    0.6310

  Bed density (per 1000 population)                                                                                                                                

   More than one to less than or equal tothree beds (ref=fewer than one bed)    −0.025 (−0.0698 to 0.0198)      0.2660               0.032 (−0.0003 to 0.0639)     0.0470

   More than three to less than or equal to five beds(ref=fewer than one bed)   −0.0469 (−0.0964 to 0.0026)     0.0620               0.0519 (0.016 to 0.0851)      0.0040

   More than five beds(ref=fewer than one bed)                                  −0.0524 (−0.1079 to 0.0032)     0.0640               0.0467 (0.0058 to 0.0874)     0.0240

  Primary completion rate, total (% of relevant age group)                      −0.0015 (−0.0028 to −0.0002)    0.0260               0.0013 (0.0005 to 0.0022)     0.0020

  Smoking prevalence, males (% of adults)                                       0.0000 (−0.0015 to 0.0016)      0.9930               0.0002 (−0.0008 to 0.0012)    0.7350

  Income group                                                                                                                                                     

   Upper middle-income(ref=low- and lower middle-income)                        0.0088 (−0.0296 to 0.0472)      0.6450               −0.0067 (−0.0357 to 0.0201)   0.6370

   High-income(ref=low and lower middle income)                                 0.0087 (−0.0403 to 0.0577)      0.7200               −0.0264 (−0.0619 to 0.0094)   0.1300

  Population live per square metre of land                                                                                                                         

   More than 100 to less than or equal to 200(ref=less than or equal to 100)    −0.0385 (−0.0775 to 0.0005)     0.0010               0.0212 (−0.004 to 0.0493)     0.1150

   More than 200(ref=less than or equal to 100)                                 −0.0654 (−0.1009 to −0.0299)    0.0000               0.0435 (0.0173 to 0.0684)     0.0010

  Constant                                                                      0.2859 (0.1534 to 0.4185)       0.0000               0.7368 (0.6431 to 0.8262)     0.0000

  Sigma                                                                         0.0444 (0.0343 to 0.0545)       --                   0.0304 (0.0197 to 0.0324)     --

  Observations summary                                                          Considering inefficiency ≤0.\                                                      
                                                                                Left-censored (4).\                                                                
                                                                                Uncensored (42).\                                                                  
                                                                                Right-censored (0).                                                                

  Number of observation                                                         46                                                   42                            

  Log likelihood/number of efficient decision-making units                      66.5                                                 4                             

  df/Number of bootstrap reps                                                   11                                                   1000                          

  Prob. \>χ^2^                                                                  0.000                                                0.000                         
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Physician density, income status of countries and smoking prevalence among males exhibited statistically insignificant associations with the health system efficiency in the both models. The density of bed (more than three to fewer than or equal to five) had a significantly negative association with the inefficiency scores (ie, positive association with the efficiency) compared with less than one bed density category. Countries having more than one and less than or equal to three bed density had no significant association with the inefficiency scores. However, after the bootstrapping, this category became significant and the significance level increased for the rest two categories (ie, more than three and less than or equal to five bed density and more than five bed density). The association of bed density in the both models indicates that sample countries with less than one bed density have lower technical efficiency of their health systems. Furthermore, the primary education completion rate was significantly negatively associated with the inefficiency score in the Tobit model, which indicates that countries with higher percentage of primary education completion rate have higher health system efficiency. Similar association was observed in the bootstrap model. In case of population density, we found in the both models that countries having more than 200 population per square kilometre were more efficient in their health system efficiency compared with the countries with less than or equal to 100 population per square kilometre.

### Sensitivity of the efficiency scores {#s3a1}

We conducted sensitivity analysis using various combinations of input and output variables. In all of these cases, the average of the efficiency scores varied from 0.812 to 0.936. The most sensitive combination was found while using the HALE at age 60 years as the outcome variable. The efficiency score changed from 0.919 (main model) to 0.812 (considering input as HALE at age 60 years) ([figure 2](#F2){ref-type="fig"}).

![Results from the sensitivity analysis of efficiency scores. CRS, constant returns to scale; DMUs, decision-making units; VRS, variable returns to scale.](bmjopen-2018-022155f02){#F2}

In [table 4](#T4){ref-type="table"}, mean efficiency scores are presented by the income categories of the countries. The highest mean VRS technical efficiency were observed for high-income countries (0.934; 95% CI 0.905 to 0.963), followed by upper middle-income (0.914; 95% CI 0.894 to 0.935), and low and lower middle income countries (0.913; 95% CI 0.891 to 0.935). If all the health systems operated at maximum efficiency at their given input level, the high-income, upper middle-income, low-income and lower middle-income countries could improve their health system outcome (eg, HALE at birth and reduce infant mortality) by 6.6%, 8.6% and 8.7% respectively.

###### 

Mean efficiency scores according to income level of Asian countries

  Income groups                        VRS technical efficiency   Percentage of output can be improved in VRS technical efficiency, %   
  ------------------------------------ -------------------------- --------------------------------------------------------------------- -----
  Low income and lower middle income   0.913                      (0.891 to 0.935)                                                      8.7
  Upper middle income                  0.914                      (0.894 to 0.935)                                                      8.6
  High income                          0.934                      (0.905 to 0.963)                                                      6.6

VRS, variable returns to scale.

Discussion {#s4}
==========

The main findings of this paper demonstrated that about 91.3% of the studied Asian countries are technically inefficient with respect to using healthcare systems resources (using a proxy of per capita health expenditure). The study findings showed that among the studied Asian countries, the majority of the efficient countries belonged to the high-income group (Cyprus, Japan and Singapore). Only one country belonged to the low- and lower middle-income group (Bangladesh). Among the 46 countries studied, only four countries (Bangladesh, Japan, Singapore and Cyprus) showed CRS efficiency, indicating that they were operating at their most efficient level. Of the 14 high-income countries studied, nine countries (75.0%) had health system production at decreasing returns to scale. This implies that although the highest number of efficient countries belonged to the high-income group, a large number of these countries' health system production had more resources than the ideal situation. A similar situation was observed for the upper middle-income countries. Of the 13 countries, 10 (76.9%) had decreasing returns to scale. Only 5 (23.8%) out of 21 low-income and lower middle-income countries were producing at decreasing returns to scale. Although these low-income and lower middle-income countries are not efficient, most of their production follows increasing returns to scale.

It was observed that the average of the efficiency scores increased from the low-income and lower middle-income countries to high-income countries. An important policy implication of this study could be that the technically inefficient low-income and lower-middle income countries on average can improve their health systems outcome by 8.7%, middle-income country by 8.6% and high-income country by 6.6% using the existing levels of per-capita health expenditure. An international study found a similar conclusion that health systems performance is most efficient in the developed countries according to simple efficiency scores.[@R64]

The overall healthcare efficiency in different countries varied considerably.[@R65] Among the low-income and lower middle-income countries studied, one country demonstrated the most efficient health systems (Bangladesh). This country has both technical and scale efficient health systems, like the high-income countries (Japan, Singapore, and Cyprus).[@R67] A possible reason for the high efficiency of this country could be a focus on infant mortality and child health as prioritised in past Millennium Development Goals and in current Sustainable Development Goals agendas, which relates to the outcome variables used in this study.

The DEA result showed that more than 60% of the low-income and lower middle-income countries had health system efficiency greater than 90%. This result implies that these countries produce good health at low cost and therefore make good use of health systems resources.[@R68] This result suggests that it is possible for countries to have a high-efficiency score with poor health outcomes because of their low expenditure on resources and increasing returns to scale production function. In other words, given their moderate consumption of inputs and challenging social environments, these countries can achieve good health outcomes, relative to the other countries. Similar findings were observed for Mexico and Turkey relative to other countries in a study of the OECD countries.[@R39] It should be noted that this study only used per-capita health expenditure and there are other factors that influence health outcomes as well. For example, differences in life expectancy and infant mortality between populations can be due to lifestyles, preferences[@R56] social class, occupation[@R71] and environmental factors.[@R72] On a more macroscopic level, the results could also be impacted by a variety of contextual factors among countries such as different political institutions, economic landscapes, health-seeking behaviour patterns and burden of diseases among other things. However, in this study, we attempted to address by including variables addressing the number of physicians, number of inpatient beds and population density, along with two environmental factors namely primary completion rate of relevant age group and smoking prevalence among the adult male population to take into consideration some of this variation. The results showed that more than three and less than five beds per 1000 population significantly influenced the efficiency score. A low number of beds cannot serve a large proportion of the population and therefore the systems may be inefficient. Similarly, a high number of beds may often be left unused and make the health systems inefficient. The countries having more than 200 people living per square kilometre had a higher level of efficiency in their health systems.

A limitation of DEA methodology is that it works in a deterministic way, meaning that the results entirely depend on the numeric values in the dataset. As the DEA approach compares DMUs, the number and nature of DMUs in the data set can noticeably change the results. For example, if a more efficient country is added to the dataset, it would move the frontier, causing some of the efficiency scores of other countries to fall. This is a key aspect of the methodology used.

Additionally, it is important to note that the use of a different set of variables might have generated different conclusions. In the future, if additional data become available for a larger number of countries in the region, the number of variables analysed could be increased to include an understanding with a greater degree of complexity in health system efficiency.

Another data limitation is the comparability of health expenditures among the Asian countries. While recognising that it is not possible to solve the inherent issues, we made an attempt to minimise it. Since the actual amount of healthcare expenditure across different countries may not be comparable due to the difference in purchasing power parity across countries, we used health expenditures as constant of 2011 in PPP as an input in the DEA model.[@R39] Also, when we included health expenditure at current USD per capita as an input in the DEA model, we found that the efficiency score did not change significantly.

We applied sensitivity analysis in an attempt to overcome these limitations ([figure 2](#F2){ref-type="fig"}). Our results were consistent while using several combinations of inputs and outputs variables, which is reassuring and strengthens the findings from this study.

Conclusions {#s5}
===========

This study provides an empirical picture of the technical efficiency of the healthcare systems of 46 Asian countries. The study shows that inefficiency exists in the healthcare systems of most of the countries studied; however, the results point to three high-income and one lower middle-income country, which efficiently used healthcare systems resources. The interpretation of the inefficient countries identified through this study is that they can improve health outcomes using the current level of per-capita health expenditure. These countries could use these results to direct their attention to benchmarking their health systems within their regional or another comparative group in order to understand their health system performance in a more detailed way. This study addresses the need to understand efficiency issues, as well as potentially identify good examples of countries that efficiently allocate and use resources to make their healthcare systems more technically efficient. It narrows a gap in the literature as there are few countries studying healthcare efficiency in Asia and looking comparatively in this manner.
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